𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of 21 Cases of Invasive Mucormycosis with Amphotericin B Colloidal Dispersion

✍ Scribed by R. Herbrecht; V. Letscher-Bru; R. A. Bowden; S. Kusne; E. J. Anaissie; J. R. Graybill; G. A. Noskin; B. A. Oppenheim; E. Andrès; L.A. Pietrelli

Publisher
Springer
Year
2001
Tongue
English
Weight
70 KB
Volume
20
Category
Article
ISSN
0934-9723

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Successful treatment of invasive aspergi
Successful treatment of invasive aspergillosis complicating prolonged treatment-related neutropenia in acute myelogenous leukemia with amphotericin B lipid complex
✍ Hospenthal, Duane R. ;Byrd, John C. ;Weiss, Raymond B. 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 365 KB

## Abstract Herein we report the successful treatment of invasive aspergillosis with the liposomal amphotericin B (AMB) formulation, Amphotericin B Lipid Complex (ABLC™). This investigational compound was employed in a 50‐year‐old patient with acute myelomonocytic leukemia complicated by prolonged,

Amphotericin B deoxycholate treatment of
Amphotericin B deoxycholate treatment of visceral leishmaniasis with newer modes of administration and precautions: a study of 938 cases
✍ C.P. Thakur; R.K. Singh; S.M. Hassan; R. Kumar; S. Narain; Ashok Kumar 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 747 KB

Out of 938 parasitologically confirmed patients with visceral leishmaniasis treated with amphotericin B (1 mg/kg bodyweight daily infused in 2 h for 20 days), 935 were cured clinically, 933 parasitologically and 931 ultimately (no relapse within 6 months). Two parasitologically 'not cured' and 4 rel